Christopher Mason
Director/Board Member chez KRYSTAL BIOTECH, INC.
Fortune : - $ au 31/03/2024
Postes actifs de Christopher Mason
Sociétés | Poste | Début | Fin |
---|---|---|---|
KRYSTAL BIOTECH, INC. | Director/Board Member | 04/01/2021 | - |
Independent Dir/Board Member | 04/01/2021 | - | |
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Director/Board Member | 01/09/2015 | - |
Founder | 01/09/2015 | - | |
London Regenerative Medicine Network Ltd. | Director/Board Member | 01/02/2008 | - |
Founder | 01/02/2008 | - | |
University College London | Corporate Officer/Principal | - | - |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | 01/10/2021 | - |
Historique de carrière de Christopher Mason
Anciens postes connus de Christopher Mason
Sociétés | Poste | Début | Fin |
---|---|---|---|
AVROBIO, INC. | Chief Tech/Sci/R&D Officer | 01/07/2015 | 30/06/2022 |
Founder | 01/07/2015 | 30/06/2022 | |
Stem Cell Translation Ltd. | Director/Board Member | 01/10/2006 | 01/03/2018 |
Founder | 01/10/2006 | 01/03/2018 | |
The British Neurological Research Trust | Director/Board Member | 01/05/2012 | 01/05/2016 |
UK Stem Cell Foundation | Director/Board Member | 01/09/2010 | 01/05/2016 |
Formation de Christopher Mason
Imperial College London | Undergraduate Degree |
University College London | Doctorate Degree |
King's College London | Doctorate Degree |
Statistiques
Internationale
Royaume-Uni | 9 |
Etats-Unis | 4 |
Opérationnelle
Director/Board Member | 8 |
Founder | 5 |
Doctorate Degree | 2 |
Sectorielle
Consumer Services | 4 |
Health Technology | 4 |
Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
AVROBIO, INC. | Health Technology |
KRYSTAL BIOTECH, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
UK Stem Cell Foundation | Miscellaneous |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
The British Neurological Research Trust | |
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
London Regenerative Medicine Network Ltd. | |
Stem Cell Translation Ltd. |
- Bourse
- Insiders
- Christopher Mason
- Expérience